Announcements
- Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Pulmonx Reports First Quarter 2024 Financial Results
- Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
- Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
- Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
- Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
- Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
- Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference
- Pulmonx to Participate at Upcoming Investor Conferences
- Pulmonx Reports Record Third Quarter 2023 Financial Results
More ▼
Key statistics
On Friday, Pulmonx Corp (4NI:BER) closed at 6.70, 0.00% above its 52-week low of 6.70, set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.70 |
---|---|
High | 6.70 |
Low | 6.70 |
Bid | 6.60 |
Offer | 6.70 |
Previous close | 6.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 38.82m |
Free float | 36.88m |
P/E (TTM) | -- |
Market cap | 281.41m USD |
EPS (TTM) | -1.54 USD |
Data delayed at least 15 minutes, as of May 31 2024 07:04 BST.
More ▼